Disney CEO Speaks on Disneyland Reopening Plans

Walt Disney Co. reopens its two California theme parks on April 30 after they were dark for more than a year, a key step in the entertainment giant’s recovery from the pandemic. CEO Bob Chapek said he’s “thrilled” with future guest reservations. Watch below for more.

 

“I think it’s going to create a reemergence scenario where magic is going to be even greater for our guests when they do come back to our parks.”

Host: What are some of the new technologies that you’ve used over the last year that you think might stick around post pandemic? Will temperature screenings continue? For example, will you use the reservation system a lot more?

Chapek: Well, in addition to all the health guidelines that we’ve been following across the world, you know, masks, temperature checks, increased hygiene, six foot social distancing, we’re also going to be introducing a new reservation system. That’s going to enable our guests to have a great time no matter when they choose to come to Disney. Of course, nobody ever wants to go through a pandemic, but our teams here have been hard at work, making sure that when we reemerge that we’re going to do. So in a way that’s actually going to improve the guest experience even versus a pre pandemic situation. And our guest satisfaction scores, since we’ve reopened across the world, have shown that indeed our guests are even more satisfied than they were prior to the pandemic.

We’ve learned some things. We’ve learned to operate under constraints all the time by delivering this great save Disney magic that you expect. But, you know, we’ve been in a fortunate situation where we’ve had a lot of demand in the past. In many cases, that has exceeded what we can actually supply in terms of how many people we can put in a park. And there’s been no situation that’s been, you know, more like that than we’ve had upon reopening and really having to operate under some really tight constraints. But we’ve gotten even better. And better at it. And I think it’s going to create a reemergence scenario where magic is going to be even greater for our guests when they do come back to our parks.

*Bloomberg contributed to this article

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

 


Follow us on social media for the latest updates in B2B!

Image

Latest

AMAG Technology
AMAG Technology: Control, Reliability, and Customer-First Supply Chain Excellence
April 2, 2025

At AMAG Technology, being customer-obsessed goes beyond a mindset—it’s built into every part of the operation. One of the company’s greatest strengths lies in its ability to manufacture its own products, offering a level of supply chain control that few competitors can match. Allan Price, Head of Global Supply Chain at AMAG, emphasizes how this…

Read More
visitor management solution
Reinventing Visitor Management Solution with Symmetry GUEST
April 2, 2025

In an age where speed and security are paramount, the traditional paper logbook is becoming a relic of the past. AMAG Technology’s Symmetry Guest system offers a modern, digital solution that redefines the way organizations welcome and manage visitors. Gone are the days of long lines and confusion at the front desk—Symmetry Guest empowers hosts…

Read More
AMAG
Driven by Customers, Defined by Innovation: Inside AMAG’s Customer-Obsessed Approach
April 2, 2025

AMAG Technology continues to strengthen its customer-obsessed culture by actively listening to both internal and external voices. As shared by Kyle Gordon, Executive Vice President of Global Sales, Marketing, & Commercial Excellence, the company is focused on improving processes, responding with speed, and driving innovation—while honoring its legacy and delivering unique value within the industry.

Read More
biotech
Biotech Moves Smarter: IDDI Powers Data-Driven Drug Innovation
April 2, 2025

As biotech innovation accelerates, small and mid-size pharmaceutical companies are becoming key players in bringing new treatments to market. Yet many of these organizations face steep challenges when navigating clinical trial design, regulatory approval, and data integrity. According to a McKinsey Global Institute report, industries like biotech could help generate up to $50 trillion…

Read More